Ticker >

Remedium Lifecare share price

Remedium Lifecare Ltd.

BSE: 539561 SECTOR: Trading  18k   52   6

142.30
+12.91 (9.98%)
BSE: 23 Feb 04:01 PM

Price Summary

Today's High

₹ 142.3

Today's Low

₹ 131.95

52 Week High

₹ 179.66

52 Week Low

₹ 8.53

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1434.38 Cr.

Enterprise Value

1412.53 Cr.

No. of Shares

10.08 Cr.

P/E

18.93

P/B

3.16

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  45.09

CASH

21.86 Cr.

DEBT

0 Cr.

Promoter Holding

1.11 %

EPS (TTM)

₹  7.52

Sales Growth

1%

ROE

70.92 %

ROCE

102.54%

Profit Growth

403.44 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year1%
3 Year460.82%
5 Year329.16%

Profit Growth

1 Year403.44%
3 Year169.57%
5 Year231.28%

ROE%

1 Year70.92%
3 Year36.25%
5 Year23.53%

ROCE %

1 Year102.54%
3 Year42.7%
5 Year27.97%

Debt/Equity

0

Price to Cash Flow

69.97

Interest Cover Ratio

17.4611618072557

CFO/PAT (5 Yr. Avg.)

2.93051696150989

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 1.11 0
Sep 2023 1.11 0
Jun 2023 1.11 0
Mar 2023 1.11 0
Dec 2022 1.11 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 169.568623755403% for the Past 3 years.
  • The company has shown a good revenue growth of 460.824376916904% for the Past 3 years.
  • Company has been maintaining healthy ROE of 36.2502729777856% over the past 3 years.
  • Company has been maintaining healthy ROCE of 42.6960408621877% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 17.4611618072557.
  • Company’s PEG ratio is 0.0469237374383964.
  • The company has an efficient Cash Conversion Cycle of 40.1012850435339 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.93051696150989.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 116.138379234684.

 Limitations

  • The company has a low EBITDA margin of -5.43871419411296% over the past 5 years.
  • The company is trading at a high PE of 18.93.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 176.48 75.58 330.47 468.57 1834.18
Total Expenditure 174.95 78.48 323.18 462.23 1779.48
Operating Profit 1.53 -2.9 7.28 6.34 54.7
Other Income 0.02 0.1 0 4.08 14.12
Interest 0.02 0 0 0 0.03
Depreciation 0.01 0.01 0.01 0.02 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.52 -2.81 7.27 10.41 68.78
Tax 0 1.97 2.02 3.88 0
Profit After Tax 1.52 -4.78 5.25 6.53 68.78
Adjusted EPS (Rs) 0.76 -2.37 2.6 3.24 34.12

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 0.16 2.89 90.03 504.79 509.84
Total Expenditure 0.23 2.5 89.31 502.98 502.67
Operating Profit -0.07 0.39 0.72 1.82 7.17
Other Income 0.09 0.01 0.01 0.01 0.83
Interest 0 0.01 0.02 0.23 0.45
Depreciation 0 0.01 0.06 0.07 0.15
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.02 0.38 0.65 1.53 7.4
Tax 0.01 0.1 0.17 0.45 1.97
Net Profit 0.01 0.28 0.48 1.08 5.43
Adjusted EPS (Rs.) 0 0.14 0.24 0.53 2.69

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 3.6 3.6 3.6 3.6 3.6
Total Reserves -0.52 -0.25 0.26 1.34 6.76
Borrowings 0.08 0.36 10.5 0 0
Other N/C liabilities 0 0 0 0 -0.01
Current liabilities 0.37 0.55 24.17 218.82 1143.86
Total Liabilities 3.53 4.27 38.53 223.76 1154.22
Assets
Net Block 0 0.23 0.21 0.19 0.08
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 3.53 4.04 38.32 223.57 1154.14
Total Assets 3.53 4.27 38.53 223.76 1154.22
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.01 0.38 0.65 1.53 7.4
Adjustment -0.09 0.01 0.06 0.18 0.19
Changes in Assets & Liabilities 0 -0.59 -10.89 10.03 14.89
Tax Paid 0.01 0 -0.04 -0.45 -1.98
Operating Cash Flow -0.07 -0.2 -10.21 11.28 20.5
Investing Cash Flow 1.06 -0.24 -0.04 -0.05 -0.04
Financing Cash Flow 0.08 0.29 10.14 -10.61 -0.04
Net Cash Flow 1.06 -0.15 -0.11 0.62 20.42

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 1.11 1.11 1.11 1.11 1.11
siddharth chimanlal shah 1.11 1.11 1.11 1.11 1.11
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 98.89 98.89 98.89 98.89 98.89
achinya securities privat... - - - - 1.31
alok ashok tiwari 1.73 1.73 1.73 1.59 1.59
amit prakash masalia 1.89 1.89 1.89 1.89 1.89
chirag narendra modh 3.81 3.81 4.20 4.20 4.20
cnm finvest private limit... 5.45 5.45 5.45 5.45 5.45
deena prakash masalia 1.81 1.81 1.81 1.81 1.81
dhansukhbhai champaklal j... 2.64 2.64 2.64 2.64 2.64
guruprasad sitaram kudva 1.46 1.46 1.46 1.46 1.46
jayashree d singh 1.60 1.60 1.60 1.60 1.60
jiteshkumar shashikantbha... 2.78 2.78 2.78 2.78 2.78
jyotika deepak shenoy 6.39 6.52 6.54 5.55 5.26
kamlesh pravinchandra - - - - 1.24
kamlesh pravinchandra sha... 2.50 2.50 2.45 2.29 2.14
kapil mahesh kothari 1.53 1.40 1.40 1.40 1.00
lalit kumar lalwani 1.79 - - - 1.79
maryam maqbool dhoki 1.94 1.94 1.94 1.94 1.94
minal uday doshi 1.09 1.09 1.09 1.08 1.07
mukesh kumar naresh 1.62 1.62 1.62 1.62 1.62
padmavathy kaimal kondath... 1.46 1.46 1.46 1.46 1.46
payal amit masalia 1.78 1.78 1.78 1.78 1.78
radhika vasanth 1.14 1.14 - - 1.14
sadhana santhosh - - - - 1.11
sathish s nayak 3.27 3.71 3.78 3.78 3.78
sheela rajendra kaimal 1.47 1.47 1.47 1.47 1.47
tulsi arvindakshan nair - - - - 1.47
uppinangady sudhindra - - - - 7.76
vasanth kumar bantwal 1.67 1.67 1.67 1.67 1.67
venkatesh bhaskar shenoy 4.01 3.98 3.98 3.99 3.99
vignesh - - - - 5.69
vishek masalia - - - - 2.95
kamlesh pravinchandra sha... 1.33 1.33 1.33 1.29 -
lalit kumar lalwani . - 1.79 1.79 1.79 -
radhika vasanth - - 1.14 1.14 -
remedium escrow suspense ... - - - 4.39 -
sadhana santhosh shanbhag... 1.11 1.11 1.11 1.11 -
tulasi arvindakshan nair 1.47 1.47 1.47 1.47 -
uppinangady sudhindra nay... 8.10 8.11 8.10 7.94 -
vignesh . - - - 5.69 -
vishek . masalia - 1.13 2.95 2.95 -
heroic mercantile 1.56 1.56 1.15 - -
sudhakar jha 1.54 1.60 1.60 - -
vignesh . 5.48 5.53 5.69 - -
prashant y parikh 1.83 1.83 - - -
dharmendra mahendra parik... 1.13 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Remedium Lifecare to acquire manufacturing facility in Hyderabad23 Feb 2024, 11:53AM Remedium Lifecare informs about board meeting 23 Feb 2024, 10:28AM Remedium Lifecare - Quaterly Results14 Feb 2024, 5:08PM Remedium Lifecare - Quaterly Results14 Feb 2024, 5:08PM Remedium Lifecare informs about record date 12 Feb 2024, 10:53AM Remedium Lifecare informs about issuance of duplicate share certificate31 Jan 2024, 10:00AM Remedium Lifecare informs about RTA certificate10 Jan 2024, 2:55PM Remedium Lifecare - Quaterly Results11 Nov 2023, 6:29PM Remedium Lifecare - Quaterly Results11 Nov 2023, 6:29PM Remedium Lifecare informs about certificate21 Oct 2023, 12:29PM Remedium Lifecare informs about resignation of CS cum CO8 Sep 2023, 4:48PM Remedium Lifecare - Quaterly Results12 Aug 2023, 2:54PM Remedium Lifecare - Quaterly Results12 Aug 2023, 2:54PM Remedium Lifecare informs about AGM notice and annual report 27 Jun 2023, 9:55AM Remedium Lifecare informs about AGM 26 Jun 2023, 2:15PM Remedium Lifecare informs about AGM26 Jun 2023, 12:39PM Remedium Lifecare planning to increase borrowing limit by issuance of debt securities15 Jun 2023, 10:22AM Remedium Lifecare - Quaterly Results30 May 2023, 8:14PM Remedium Lifecare - Quaterly Results30 May 2023, 8:14PM Remedium Lifecare informs about compliance certificate19 Apr 2023, 5:06PM Remedium Lifecare informs about newspaper publication 9 Feb 2023, 5:04PM Remedium Lifecare - Quaterly Results7 Feb 2023, 5:49PM Remedium Lifecare - Quaterly Results7 Feb 2023, 5:49PM Remedium Lifecare - Quaterly Results7 Feb 2023, 5:49PM Remedium Lifecare informs about scheme of arrangement17 Dec 2022, 10:23AM Remedium Lifecare gets nod to merge MVK Lifesciences with itself15 Nov 2022, 5:41PM Remedium Lifecare - Quaterly Results4 Nov 2022, 6:44PM Remedium Lifecare - Quaterly Results4 Nov 2022, 6:44PM Remedium Lifecare informs about outcome of 33rd AGM 20 Sep 2022, 3:05PM Remedium Lifecare - Quaterly Results9 Feb 2022, 6:19PM Remedium Lifecare - Quaterly Results9 Feb 2022, 6:19PM Remedium Lifecare informs about 32nd AGM31 Aug 2021, 10:03AM Remedium Lifecare informs about newspaper clippings 12 Jul 2021, 3:43PM Remedium Lifecare informs about disclosure14 Jun 2021, 2:12PM Remedium Lifecare informs about change in registered office address12 May 2021, 1:39PM Remedium Lifecare submits disclosure14 Apr 2021, 1:06PM Remedium Lifecare submits disclosure 10 Apr 2021, 11:27AM Remedium Lifecare inform about disclosure23 Mar 2021, 3:52PM Roxy Exports informs about board meeting11 Jul 2020, 10:53AM Roxy Exports informs about board meeting20 Jun 2020, 11:11AM

Remedium Lifecare Stock Price Analysis and Quick Research Report. Is Remedium Lifecare an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Remedium Lifecare has a PE ratio of 18.9309280544913 which is high and comparatively overvalued .

  • Share Price: - The current share price of Remedium Lifecare is Rs 142.3. One can use valuation calculators of ticker to know if Remedium Lifecare share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Remedium Lifecare has ROA of 0.787548887074305 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Remedium Lifecare has a Current ratio of 1.00898607729768 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Remedium Lifecare has a ROE of 70.9178238849861 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Remedium Lifecare has a D/E ratio of 0 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Remedium Lifecare has an Inventory turnover ratio of 11.1813382868647 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Remedium Lifecare has reported revenue growth of 0.999362311479257 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Remedium Lifecare for the current financial year is 1.40619563209076 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Remedium Lifecare is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Remedium Lifecare
X